Welcome to our dedicated page for Baxter International news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter International stock.
Baxter International Inc. (NYSE: BAX) is a global healthcare company dedicated to providing essential renal and hospital products. With a comprehensive portfolio that includes home, acute, and in-center dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition, biosurgery products, anesthetics, and pharmacy automation, Baxter plays a critical role in expanding access to healthcare worldwide.
Baxter's recent acquisition of Hillrom in late 2021 has significantly enhanced its hospital-focused offerings. This acquisition brought basic equipment like hospital beds under Baxter’s umbrella, along with advanced digital solutions such as smart beds and the Voalte medical communications app. These additions complement Baxter’s legacy operations, which focus on products for patients with acute and chronic kidney failure. Notably, Baxter plans to spin off its renal care segment by mid-2024.
Additionally, Baxter provides a variety of injectable therapies, including IV pumps, administrative sets, and nutritional products, as well as surgical sealants and hemostatic agents used in various care settings. The company’s extensive global footprint and the essential nature of its products and services underscore its commitment to advancing healthcare innovations and improving patient care in both emerging and developed markets.
Baxter’s financial condition remains robust, bolstered by its continuous innovation and strategic partnerships. The company’s employees worldwide are dedicated to building upon a rich heritage of medical breakthroughs, ensuring that Baxter continues to be at the forefront of healthcare advancements.
Baxter International (NYSE:BAX) has received FDA 510(k) clearance for its new Novum IQ syringe infusion pump, which features Dose IQ
Baxter International Inc. (NYSE:BAX) will present at the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 10:25 a.m. Eastern Time. CFO Jay Saccaro is scheduled to discuss the company’s innovations and healthcare solutions. A live webcast of the presentation can be accessed at www.baxter.com and will be available for replay until February 23, 2023. Baxter has a 90-year history of providing critical healthcare products and services globally, impacting millions of patients and caregivers.
Baxter International Inc. (NYSE:BAX) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022. Jay Saccaro, Chief Financial Officer, is set to present at 10:35 a.m. Eastern Time. A live webcast of the presentation will be available on Baxter's website and can be replayed until March 13, 2023. Baxter has a long-standing history of providing essential medical products and innovations that improve healthcare across more than 100 countries.
Baxter International Inc. (NYSE:BAX) reported second-quarter 2022 revenue of $3.75 billion, marking a 21% increase on a reported basis and a 26% increase on a constant currency basis. U.S. GAAP EPS was $0.50, with adjusted EPS at $0.87. The company anticipates full-year sales growth in the high teens and forecasts U.S. GAAP EPS between $1.82 and $1.92. Despite operational challenges, including supply chain issues, Baxter's acquisition of Hillrom contributed significantly to performance, generating $715 million in sales.
Baxter International Inc. (NYSE:BAX) has declared a quarterly cash dividend of $0.29 per share, payable on October 3, 2022, to shareholders on record as of September 2, 2022. This brings the indicated annual dividend rate to $1.16 per share. Baxter, a leader in medical technology, provides critical care and innovative healthcare solutions globally, with a mission to save and sustain lives. The company emphasizes its commitment to shareholder value through consistent dividend payments, though future payouts may vary based on financial conditions.
Baxter International Inc. (NYSE:BAX) will host a conference call on July 28, 2022, at 7:30 a.m. CT to discuss its second-quarter financial results. Interested participants can join the call via a pre-registration link or through Baxter's website. The call will be recorded and is copyrighted material.
Baxter has been a leader in medtech for 90 years, providing essential products and solutions across various care settings globally, impacting millions of patients and caregivers daily. For more information, visit www.baxter.com.
Baxter International Inc. (NYSE:BAX) is set to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 10:40 a.m. Pacific Time. José Almeida, the company’s CEO, will lead the presentation. The event will feature a live webcast, accessible at www.baxter.com, with replay available until June 13, 2023. Baxter continues to deliver critical healthcare solutions globally, enhancing patient care for nearly a century.
Baxter International (NYSE:BAX) hosted its 2022 Investor Conference, outlining its strategy for growth and innovation following the Dec. 2021 acquisition of Hillrom. The company aims to enhance patient care and operational efficiency, expecting constant currency sales growth of 4-5% from 2022-2025, with a projected adjusted operating margin increase of 350-400 basis points by 2025. Baxter anticipates $350 million in annual cost synergies and $200 million in revenue synergies by 2025 from the acquisition. Innovations showcased include the Sharesource platform and Voalte communication technologies.
FAQ
What is the current stock price of Baxter International (BAX)?
What is the market cap of Baxter International (BAX)?
What does Baxter International Inc. specialize in?
What was the impact of Baxter's acquisition of Hillrom?
What products does Baxter offer for kidney failure patients?
What are some of Baxter's injectable therapies?
What surgical products does Baxter provide?
What is Baxter's plan for its renal care segment?
How does Baxter contribute to global healthcare access?
How does Baxter ensure continuous innovation?
What are some of the digital solutions offered by Baxter?
What is Baxter's commitment to patient care?
